{"transactions":[{"id":1508649,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-20T20:02:44.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":11464,"price":6.47,"value":74172.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock (the \"Shares\") sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price of the Shares. The Shares were sold in multiple transactions at prices ranging from $6.46 to $6.56 per Share. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the Securities Exchange Commission staff, upon request, information regarding the number of Shares sold at each price within the range."}],"balance_after":1821872,"source":{"system":"sec-edgar","filing":"0001104659-24-063560","document":"tm2414961-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465924063560/tm2414961-3_4seq1.xml","form_type":"4"}},{"id":1886566,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Common Stock","published_at":"2023-05-18T20:35:22.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":7861,"price":18.05,"value":141891.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.05 to $18.23. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":1833336,"source":{"system":"sec-edgar","filing":"0001104659-23-062377","document":"tm2316199-8_3seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465923062377/tm2316199-8_3seq1.xml","form_type":"4"}},{"id":1927103,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-04T20:00:41.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2024, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":67500,"derivative":{"exercise_price":17.66,"expiration_date":"2033-04-01","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001104659-23-041718","document":"tm2311410-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465923041718/tm2311410-2_4seq1.xml","form_type":"4"}},{"id":1927102,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Common Stock","published_at":"2023-04-04T20:00:41.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2024 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2027, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":1841197,"source":{"system":"sec-edgar","filing":"0001104659-23-041718","document":"tm2311410-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465923041718/tm2311410-2_4seq1.xml","form_type":"4"}},{"id":2265325,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-05-18T19:01:19.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":5737,"price":14.59,"value":83702.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person."}],"balance_after":1796197,"source":{"system":"sec-edgar","filing":"0001104659-22-062606","document":"tm2215879d3_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465922062606/tm2215879d3_4seq.xml","form_type":"4"}},{"id":2303750,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-05T16:18:04.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":39375,"derivative":{"exercise_price":18.26,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001104659-22-042771","document":"tm2211665-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465922042771/tm2211665-2_4seq1.xml","form_type":"4"}},{"id":2303749,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Common Stock","published_at":"2022-04-05T16:18:04.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2023 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2026, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":1801934,"source":{"system":"sec-edgar","filing":"0001104659-22-042771","document":"tm2211665-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465922042771/tm2211665-2_4seq1.xml","form_type":"4"}},{"id":2639134,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-07-07T21:01:01.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":7810,"price":40.04,"value":312712.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 16, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.13. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,775,684 shares of the Issuer's common stock. The reporting person also holds options to acquire 1,092,899 shares of the Issuer's common stock, 645,394 of which are exercisable as of the date hereof."}],"balance_after":1775684,"source":{"system":"sec-edgar","filing":"0001104659-21-089919","document":"tm2121160-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465921089919/tm2121160-2_4seq1.xml","form_type":"4"}},{"id":2649521,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-06-30T21:00:45.000Z","date":"2021-06-29","kind":"sale","acquired":false,"shares":22826,"price":40.05,"value":914181.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 16, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.21. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,783,494 shares of the Issuer's common stock. The reporting person also holds options to acquire 1,092,899 shares of the Issuer's common stock, 635,306 of which are exercisable as of the date hereof."}],"balance_after":1783494,"source":{"system":"sec-edgar","filing":"0001104659-21-087803","document":"tm2121160-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465921087803/tm2121160-1_4seq1.xml","form_type":"4"}},{"id":2649520,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-06-30T21:00:45.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":14663,"price":40.04,"value":587106.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 16, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.15. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":1806320,"source":{"system":"sec-edgar","filing":"0001104659-21-087803","document":"tm2121160-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465921087803/tm2121160-1_4seq1.xml","form_type":"4"}},{"id":2757112,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-04-05T20:18:23.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":115300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2022, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":115300,"derivative":{"exercise_price":31.58,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":115300},"source":{"system":"sec-edgar","filing":"0001104659-21-046729","document":"tm2112099-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465921046729/tm2112099-11_4seq1.xml","form_type":"4"}},{"id":2757111,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-04-05T20:18:23.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":76865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2022 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2025, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":1820983,"source":{"system":"sec-edgar","filing":"0001104659-21-046729","document":"tm2112099-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465921046729/tm2112099-11_4seq1.xml","form_type":"4"}},{"id":2894881,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-01-26T21:00:21.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":29803,"price":43.99,"value":1311033.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 16, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.41 to $44.37. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,744,118 shares of the Issuer's common stock. The reporting person also holds options to acquire 977,599 shares of the Issuer's common stock, 483,771 of which are exercisable as of the date hereof."}],"balance_after":1744118,"source":{"system":"sec-edgar","filing":"0001104659-21-007820","document":"tm213368d7_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465921007820/tm213368d7_4.xml","form_type":"4"}},{"id":2894880,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Common Stock","published_at":"2021-01-26T21:00:21.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":30197,"price":44.87,"value":1354939.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 16, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.38 to $45.37. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":1773921,"source":{"system":"sec-edgar","filing":"0001104659-21-007820","document":"tm213368d7_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465921007820/tm213368d7_4.xml","form_type":"4"}},{"id":2930988,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Common Stock","published_at":"2020-12-28T21:03:30.000Z","date":"2020-12-22","kind":"sale","acquired":false,"shares":220000,"price":40.04,"value":8808800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 16, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,804,118 shares of the Issuer's common stock. The reporting person also holds options to acquire 977,599 shares of the Issuer's common stock, 468,928 of which are exercisable as of the date hereof."}],"balance_after":1804118,"source":{"system":"sec-edgar","filing":"0001104659-20-139953","document":"tm2039457-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465920139953/tm2039457-2_4seq1.xml","form_type":"4"}},{"id":3084831,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Common Stock","published_at":"2020-07-10T21:00:25.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":24250,"price":21.02,"value":509735.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 2,024,118 shares of the Issuer's common stock. The reporting person also holds options to acquire 977,599 shares of the Issuer's common stock, 384,438 of which are exercisable as of the date hereof."}],"balance_after":2024118,"source":{"system":"sec-edgar","filing":"0001104659-20-082857","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465920082857/a4.xml","form_type":"4"}},{"id":3084830,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Chief R&D Officer"}}],"security":"Common Stock","published_at":"2020-07-10T21:00:25.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":145500,"price":22.32,"value":3247560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.8167 to $22.7299."}],"balance_after":2048368,"source":{"system":"sec-edgar","filing":"0001104659-20-082857","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465920082857/a4.xml","form_type":"4"}},{"id":3185885,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres & Chief Res & Dev Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-02T16:31:03.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":265000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this stock option vest on April 1, 2021, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":265000,"derivative":{"exercise_price":9.78,"expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":265000},"source":{"system":"sec-edgar","filing":"0001104659-20-042499","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465920042499/a4.xml","form_type":"4"}},{"id":3252386,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres & Chief Res & Dev Officer"}}],"security":"Common Stock","published_at":"2020-02-24T16:02:00.000Z","date":"2020-02-20","kind":"sale","acquired":false,"shares":24250,"price":17.04,"value":413220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 2,193,868 shares of the Issuer's common stock. The reporting person also holds options to acquire 712,599 shares of the Issuer's common stock, 268,179 of which are exercisable as of the date hereof."}],"balance_after":2193868,"source":{"system":"sec-edgar","filing":"0001104659-20-024250","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465920024250/a4.xml","form_type":"4"}},{"id":3270027,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres & Chief Res & Dev Officer"}}],"security":"Common Stock","published_at":"2020-02-14T16:00:37.000Z","date":"2020-02-12","kind":"sale","acquired":false,"shares":24250,"price":17.03,"value":412977.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 2,218,118 shares of the Issuer's common stock. The reporting person also holds options to acquire 712,599 shares of the Issuer's common stock, 264,534 of which are exercisable as of the date hereof."}],"balance_after":2218118,"source":{"system":"sec-edgar","filing":"0001104659-20-021648","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465920021648/a4.xml","form_type":"4"}},{"id":3270026,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres & Chief Res & Dev Officer"}}],"security":"Common Stock","published_at":"2020-02-14T16:00:37.000Z","date":"2020-02-12","kind":"sale","acquired":false,"shares":24250,"price":17.04,"value":413220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2242368,"source":{"system":"sec-edgar","filing":"0001104659-20-021648","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465920021648/a4.xml","form_type":"4"}},{"id":3376200,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-08T21:15:40.000Z","date":"2019-11-06","kind":"sale","acquired":false,"shares":24250,"price":17,"value":412250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 2,266,618 shares of the Issuer's common stock. The reporting person also holds options to acquire 712,599 shares of the Issuer's common stock, 233,709 of which are exercisable as of the date hereof."}],"balance_after":2266618,"source":{"system":"sec-edgar","filing":"0001104659-19-061830","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465919061830/a4.xml","form_type":"4"}},{"id":3376199,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-08T21:15:40.000Z","date":"2019-11-06","kind":"sale","acquired":false,"shares":24250,"price":17.02,"value":412735.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2290868,"source":{"system":"sec-edgar","filing":"0001104659-19-061830","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465919061830/a4.xml","form_type":"4"}},{"id":3378513,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-06T19:37:28.000Z","date":"2019-11-04","kind":"sale","acquired":false,"shares":24250,"price":17,"value":412250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sales reported on this Form 4, the reporting person continues to beneficially own 2,315,118 shares of the Issuer's common stock. The reporting person also holds options to acquire 712,599 shares of the Issuer's common stock, 233,709 of which are exercisable as of the date hereof."}],"balance_after":2315118,"source":{"system":"sec-edgar","filing":"0001104659-19-060673","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465919060673/a4.xml","form_type":"4"}},{"id":3378512,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-06T19:37:28.000Z","date":"2019-11-04","kind":"sale","acquired":false,"shares":24250,"price":17.052,"value":413511.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."}],"balance_after":2339368,"source":{"system":"sec-edgar","filing":"0001104659-19-060673","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465919060673/a4.xml","form_type":"4"}},{"id":3381796,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-04T16:17:20.000Z","date":"2019-10-31","kind":"sale","acquired":false,"shares":24250,"price":17,"value":412250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sale reported on this Form 4, the reporting person continues to beneficially own 2,363,618 shares of the Issuer's common stock. The reporting person also holds options to acquire 712,599 shares of the Issuer's common stock, 233,709 of which are exercisable as of the date hereof."}],"balance_after":2363618,"source":{"system":"sec-edgar","filing":"0001104659-19-059510","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465919059510/a4.xml","form_type":"4"}},{"id":3406190,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-09-25T16:30:45.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":24250,"price":17.05,"value":413462.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the sale reported on this Form 4, the reporting person continues to beneficially own 2,387,868 shares of the Issuer's common stock. The reporting person also holds options to acquire 712,599 shares of the Issuer's common stock, 216,804 of which are exercisable as of the date hereof."}],"balance_after":2387868,"source":{"system":"sec-edgar","filing":"0001104659-19-051350","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465919051350/a4.xml","form_type":"4"}},{"id":3563950,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and C.E.O."}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-03T17:22:23.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":219300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this stock option vest on April 1, 2020, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":219300,"derivative":{"exercise_price":15.5,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":219300},"source":{"system":"sec-edgar","filing":"0001104659-19-019706","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465919019706/a4.xml","form_type":"4"}},{"id":3860709,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":90811,"kind":"person","name":"Coffin Robert","position":1,"cik":"0001376492","reported_name":"Coffin Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and C.E.O."}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-07-26T17:16:34.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 19, 2018 subject to the completion of the Issuer's initial public offering, which closed on July 24, 2018. 25% of the shares underlying this stock option vest on July 19, 2019 and the remainder of the shares underlying this stock option vest in 36 equal monthly installments thereafter."}],"balance_after":175000,"derivative":{"exercise_price":15,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001104659-18-047447","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376492/000110465918047447/a4.xml","form_type":"4"}}]}